Regramostim
- Generic Name
- Regramostim
- Brand Names
- -
- Drug Type
- Biotech
- Chemical Formula
- -
- CAS Number
- 127757-91-9
- Unique Ingredient Identifier
- KR89Q40F01
- Background
Regramostim (GM-CSF) is a differentially glycosylated factor produced mainly by activated T cells and macrophages. Endothelial cells and fibroblasts can also produce GM-CSF after exposure to TNF-α, IL-1, IL-2 and IFN-γ. GM-CSF is found associated with extracellular matrix and in membrane-bound formats too. GM-CSF stimulates proliferation, activation and diff...
- Indication
Investigated for use/treatment in adverse effects (chemotherapy) and bone marrow transplant.
- Associated Conditions
- -
- Associated Therapies
- -
A Personalized NeoAntigen Cancer Vaccine Combined With Anti-PD-1 in Melanoma
- Conditions
- Interventions
- First Posted Date
- 2019-08-28
- Last Posted Date
- 2020-04-28
- Lead Sponsor
- Xiangya Hospital of Central South University
- Target Recruit Count
- 30
- Registration Number
- NCT04072900
- Locations
- 🇨🇳
Xiangya Hospital, Central South University, Changsha, Hunan, China
Abscopal Effect of Radiation in Combination With rhGM-CSF for Metastatic Non-small Cell Lung Cancer
- First Posted Date
- 2017-04-14
- Last Posted Date
- 2023-06-13
- Lead Sponsor
- Peking University Cancer Hospital & Institute
- Target Recruit Count
- 40
- Registration Number
- NCT03113851
- Locations
- 🇨🇳
Beijing Cancer Hospital, Beijing, Beijing, China
A Study of SBRT in Combination With rhGM-CSF for Stage IV NSCLC Patients Who Failed in Second-line Chemotherapy
- Conditions
- Interventions
- First Posted Date
- 2015-12-07
- Last Posted Date
- 2018-10-15
- Lead Sponsor
- Wuhan University
- Registration Number
- NCT02623595
- Locations
- 🇨🇳
Zhongnan hospital of Wuhan university, Wuhan, Hubei, China
RhGM-CSF as Adjuvant Immunotherapy in Treating Stage III Colon Cancer
- First Posted Date
- 2015-06-09
- Last Posted Date
- 2016-01-20
- Target Recruit Count
- 60
- Registration Number
- NCT02466906
- Locations
- 🇨🇳
307 Hospital of PLA, Beijing, Beijing, China
Study of Subcutaneous Injection of Low-dose rhGM-CSF +/- WLL in PAP.
- Conditions
- Interventions
- First Posted Date
- 2013-11-14
- Last Posted Date
- 2013-11-18
- Lead Sponsor
- Shanghai Pulmonary Hospital, Shanghai, China
- Target Recruit Count
- 40
- Registration Number
- NCT01983657
- Locations
- 🇨🇳
Shanghai Pulmonary Hospital, Shanghai, China
Recombinant Human Granulocyte Macrophage Colony Stimulating Factor(rhGM-CSF) Treating Oral Mucositis
- First Posted Date
- 2013-03-07
- Last Posted Date
- 2013-03-29
- Lead Sponsor
- Wei LUO
- Target Recruit Count
- 160
- Registration Number
- NCT01806272
- Locations
- 🇨🇳
Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, China
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.